Insmed
INSM
#730
Rank
โ‚น3.065 T
Marketcap
โ‚น14,376
Share price
-0.60%
Change (1 day)
113.26%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: โ‚น3.065 Trillion

As of February 2026 Insmed has a market cap of โ‚น3.065 Trillion. This makes Insmed the world's 730th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น3.065 T-9.97%
2025โ‚น3.405 T218.77%
2024โ‚น1.068 T189.46%
2023โ‚น369.08 B64.78%
2022โ‚น223.99 B-6.67%
2021โ‚น240.00 B-3.23%
2020โ‚น248.01 B62.39%
2019โ‚น152.72 B115.34%
2018โ‚น70.92 B-53.49%
2017โ‚น152.48 B174.1%
2016โ‚น55.63 B-25.39%
2015โ‚น74.55 B52.68%
2014โ‚น48.83 B18.8%
2013โ‚น41.10 B256.38%
2012โ‚น11.53 B187.87%
2011โ‚น4.00 B-9.45%
2010โ‚น4.42 B-4.89%
2009โ‚น4.65 B69.26%
2008โ‚น2.74 B-30.36%
2007โ‚น3.94 B-0.06%
2006โ‚น3.94 B-33.03%
2005โ‚น5.89 B37.94%
2004โ‚น4.27 B-17.65%
2003โ‚น5.19 B626.6%
2002โ‚น0.71 B-88.23%
2001โ‚น6.07 B14.31%
2000โ‚น5.31 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Insmed was reported to be:

โ‚น3.065 Trillion
by Nasdaq info icon info icon
โ‚น3.065 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚น26.143 T 752.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น16.140 T 426.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น11.040 T 260.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น195.32 B-93.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น69.06 B-97.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น158.52 B-94.83%๐Ÿ‡บ๐Ÿ‡ธ USA